Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor–alpha
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference60 articles.
1. , , . Hierarchy of tumor cell sensitivity and resistance to cytolysis by TNF, cytotoxic cells, bacterial toxins, and cytotoxic drugs. In: , editors. Tumor necrosis factor: structure, mechanism of action, role in disease and therapy. Basel: S Karger, 1990: 125–32.
2. Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins
3. Cisplatin and Cyclophosphamide in Advanced Ovarian Carcinoma
4. Cisplatin Combined With Carboplatin: A New Way of Intensification of Platinum Dose in the Treatment of Advanced Ovarian Cancer
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Significance of POU5F1P1 rs10505477 Polymorphism in Chinese Gastric Cancer Patients Receving Cisplatin-Based Chemotherapy after Surgical Resection;International Journal of Molecular Sciences;2014-07-18
2. Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo;Molecular Medicine Reports;2013-03-28
3. Combined treatment with TNF-α/gefitinib alleviates the resistance to gefitinib in PC-9 cells;Anti-Cancer Drugs;2009-10
4. Resistance to chemotherapy and hormone therapy in endometrial cancer;Endocrine-Related Cancer;2009-06
5. ‘Iron‐saturated’ lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy;Immunology & Cell Biology;2008-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3